Article
Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.
Scientific reports - 15 May 2017
Kim Yeo Jin, Seo Sang Won, Park Seong Beom, Yang Jin Ju, Lee Jin San, Lee Juyoun, Jang Young Kyoung, Kim Sung Tae, Lee Kyung-Han, Lee Jong Min, Lee Jae-Hong, Kim Jae Seung, Na Duk L, Kim Hee Jin
Abstract excerpt
Although the association between apolipoprotein E (APOE) genotype and disease progression is well characterized in patients with Alzheimer's disease, such a relationship is unknown in patients with subcortical vascular cognitive impairment. We evaluated whether APOE genotype is associated with disease progression in subcortical vascular mild cognitive impairment (svMCI) patients. We prospectively recruited 72...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
